Search

In Stock

Buy Takhzyro (lanadelumab) Online

DISEASE INDICATIONS: Hereditary angioedema (HAE)

MANUFACTURER: Shire Pharmaceuticals

USAGE: Subcutaneous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Takhzyro (lanadelumab) is a prescription medication used to prevent attacks of hereditary angioedema (HAE) in people 2 years of age and older. HAE is a rare genetic disorder that causes episodes of swelling in the face, throat, abdomen, hands, and feet. These episodes can be life-threatening.

$14,055.70

Clear
Compare

Takhzyro (lanadelumab) is a prescription medication used to prevent attacks of hereditary angioedema (HAE) in people 2 years of age and older. HAE is a rare genetic disorder that causes episodes of swelling in the skin, throat, abdomen, and other parts of the body. These attacks can be life-threatening if they affect the airway.

Takhzyro is a monoclonal antibody that works by blocking the activity of plasma kallikrein, a protein that plays a key role in the development of HAE attacks.

Uses

Takhzyro is used to prevent attacks of HAE in people 2 years of age and older. It is not known if Takhzyro is safe and effective in children under 2 years of age.

Storage Conditions

Takhzyro should be stored in the refrigerator at 36°F to 46°F (2°C to 8°C). Do not freeze. Takhzyro can be kept at room temperature for up to 24 hours.

Mechanism of Action

Takhzyro is a monoclonal antibody that binds to plasma kallikrein and blocks its activity. Plasma kallikrein is a protein that plays a key role in the development of HAE attacks. By blocking the activity of plasma kallikrein, Takhzyro can help to prevent HAE attacks from occurring.

How to Use

Takhzyro is administered by subcutaneous injection every 2 weeks. The recommended dose is 300 mg. Takhzyro can be self-administered or administered by a caregiver.

Important Safety Information

Takhzyro can increase the risk of serious infections, including tuberculosis. Before starting Takhzyro, your doctor will test you for tuberculosis. Takhzyro can also reactivate latent tuberculosis infection.

Takhzyro can also increase the risk of other side effects, such as:

  • Allergic reactions
  • Injection site reactions
  • Upper respiratory tract infections
  • Headache
  • Rash
  • Diarrhea
  • Nausea
  • Fatigue

Indications

Takhzyro is indicated for the routine prevention of recurrent attacks of HAE in patients 2 years of age and older.

Precautions

Takhzyro should be used with caution in patients with a history of serious infections, tuberculosis, or other autoimmune diseases.

Takhzyro should not be used in patients who have a history of severe allergic reactions to Takhzyro or other biologic medications.

Interactions

Takhzyro may interact with other medications, including live vaccines and biologic medications. Be sure to tell your doctor about all of the medications you are taking before starting Takhzyro.

Contraindications

Takhzyro is contraindicated in patients with a history of severe allergic reactions to Takhzyro or other biologic medications.

Overdose

There is no known overdose of Takhzyro.

Side Effects

The most common side effects of Takhzyro are injection site reactions, upper respiratory tract infections, headache, rash, diarrhea, nausea, and fatigue.

More serious side effects of Takhzyro include serious infections and allergic reactions.

If you experience any side effects while taking Takhzyro, be sure to tell your doctor.

Please note: This information is not intended to be a substitute for professional medical advice. Always talk to your doctor about the best treatment for you.

Package

300 mg solution for injection

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Zoryve (roflumilast) Online

$1,026.40
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Arcutis Biotherapeutics, Inc. USAGE: Cutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Zoryve (roflumilast) is a topical cream used to treat plaque psoriasis in adults and children 12 years of age and older. It works by blocking an enzyme called phosphodiesterase 4 (PDE4), which plays a role in inflammation.

Buy Ilumya (tildrakizumab) Online

(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Almirall, S.A. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Ilumya (tildrakizumab) is a prescription medication used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is a monoclonal antibody that works by blocking the p19 subunit of interleukin-23 (IL-23), a cytokine that plays a key role in the development and progression of psoriasis.

Buy Spevigo (spesolimab-sbzo) Online

(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Boehringer Ingelheim USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Spevigo (spesolimab-sbzo) is a prescription medication used to treat generalized pustular psoriasis (GPP) flares in adults. GPP is a rare autoinflammatory skin disease that can cause painful pustules (blisters) to form all over the body. Spevigo is the first FDA-approved treatment for GPP flares.

Buy Skyrizi (Risankizumab) Online

From $14,517.47
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: AbbVie Ltd USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Therapeutic Goods Administration (TGA) Skyrizi (risankizumab) is a prescription medication used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is a monoclonal antibody that works by blocking the interleukin-23 (IL-23) pathway, which is involved in the development and progression of psoriasis.

Buy Taltz (ixekizumab) Online

From $2,499.58
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Taltz (ixekizumab) is a prescription medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis in adults. It is a monoclonal antibody that works by blocking interleukin 17A (IL-17A), a cytokine that plays a key role in the development and progression of these inflammatory diseases.

Buy Olumiant (baricitinib) Online

From $1,070.33
(0 Reviews)
DISEASE INDICATIONS: Rheumatoid Arthritis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Olumiant (baricitinib) is a prescription medication used to treat rheumatoid arthritis (RA), alopecia areata, and COVID-19. It is a Janus kinase (JAK) inhibitor, which means that it blocks the activity of JAK enzymes. JAK enzymes are involved in the signaling pathway that leads to inflammation.

Buy Skilarence (dimethyl fumarate) Online

From $93.21
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Almirall, S.A. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Skilarence (dimethyl fumarate) is a prescription medication used to treat moderate to severe plaque psoriasis in adults. It is an oral medication that works by suppressing the immune system and reducing inflammation.

Back to Top
Product has been added to your cart